Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical observations with Péflacine

E Ludwig1, E Székely, M Arr

  • 1Department A of Medicine, Hospital Municipal Pèterfy Sándor.

Therapia Hungarica (English Edition)
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of process temperature and residence time on the manufacturing of amorphous solid dispersions in hot melt extrusion.

Pharmaceutical development and technology·2022
Same author

STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.

Pathology oncology research : POR·2019
Same author

Dissemination of NDM-1 carbapenemase-producer Providencia stuartii strains in Romanian hospitals: a multicentre study.

The Journal of hospital infection·2019
Same author

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.

Acta neurologica Scandinavica·2018
Same author

Illumina short-read and MinION long-read WGS to characterize the molecular epidemiology of an NDM-1 Serratia marcescens outbreak in Romania.

The Journal of antimicrobial chemotherapy·2017
Same author

Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced Cancer.

CPT: pharmacometrics & systems pharmacology·2017
Same journal

Use of Brulamycin (tobramycin) eye drops in the preoperative and postoperative treatment of ophthalmotomies.

Therapia Hungarica (English edition)·1994
Same journal

Observations with Nitromint aerosol in everyday clinical practice.

Therapia Hungarica (English edition)·1994
Same journal

The effect of Taleum (sodium cromoglycate) 1-mg inhalation aerosol in children with allergic asthma.

Therapia Hungarica (English edition)·1994
Same journal

The pharmacology of sodium cromoglycate.

Therapia Hungarica (English edition)·1994
Same journal

Non-steroidal anti-inflammatory drugs in everyday practice.

Therapia Hungarica (English edition)·1994
Same journal

Use of 20-mg Hotemin capsule and suppository in rheumatological practice.

Therapia Hungarica (English edition)·1994
See all related articles

Pefloxacin effectively treats severe hospital-acquired infections, including urinary tract, hepatic-biliary, and respiratory infections. Oral and intravenous administration showed similar efficacy with a low side-effect rate.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Hospital-acquired infections (HAIs) pose significant treatment challenges.
  • Pefloxacin is an antibiotic with potential for treating severe infections.
  • Existing data on pefloxacin's efficacy in HAIs may be inconsistent.

Purpose of the Study:

  • To evaluate the efficacy and safety of pefloxacin in treating severe hospital-acquired infections.
  • To compare the effectiveness of oral versus intravenous pefloxacin administration.
  • To document the incidence of side-effects associated with pefloxacin treatment.

Main Methods:

  • Clinical study involving patients with severe hospital-acquired infections.
  • Treatment administered via oral and intravenous routes.

Related Experiment Videos

  • Infections targeted included urinary tract, hepatic-biliary tract, and lower respiratory tract.
  • Adverse events were systematically recorded.

    • Main Results:

    • Pefloxacin demonstrated successful treatment outcomes in severe HAIs.
    • No significant difference in efficacy was observed between oral and intravenous pefloxacin.
    • Side-effects were reported in only 10% of patients, indicating a favorable safety profile.

    Conclusions:

    • Pefloxacin is an effective and safe therapeutic option for severe hospital-acquired infections.
    • Both oral and intravenous routes of administration are viable for pefloxacin.
    • Further research may explore pefloxacin's role in specific infection types.